Title:
COMPOUNDS AS HEPATITIS C INHIBITORS AND USES THEREOF IN MEDICINE
Document Type and Number:
WIPO Patent Application WO/2016/127859
Kind Code:
A1
Abstract:
Provided herein are compounds as hepatitis C inhibitors and uses thereof in medicine. Specifically, provided herein is a compound of Formula (I) or a stereoisomer, a tautomer, an enantiomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or hepatitis C diseases. Also provided herein are a pharmaceutically acceptable composition containing such compound and a method of treating HCV infection or hepatitis C diseases comprising administering the compound or pharmaceutical composition thereof disclosed herein.
More Like This:
Inventors:
ZHANG YINGJUN (CN)
LUO HUICHAO (CN)
REN QINGYUN (CN)
XIONG ZHIMIN (CN)
LIU YANG (CN)
LEI YIBO (CN)
XIONG JINFENG (CN)
ZHANG JIANCUN (CN)
LUO HUICHAO (CN)
REN QINGYUN (CN)
XIONG ZHIMIN (CN)
LIU YANG (CN)
LEI YIBO (CN)
XIONG JINFENG (CN)
ZHANG JIANCUN (CN)
Application Number:
PCT/CN2016/073156
Publication Date:
August 18, 2016
Filing Date:
February 02, 2016
Export Citation:
Assignee:
SUNSHINE LAKE PHARMA CO LTD (CN)
International Classes:
C07D519/00; A61K31/395; A61P1/16; A61P31/14
Domestic Patent References:
WO2010088394A1 | 2010-08-05 |
Other References:
KAZMIERSKI, W. M. ET AL.: "Discovery of Novel Urea-Based Hepatitis C Protease Inhibitors with High Potency against Protease-Inhibitor-Resistant Mutants", J. MED. CHEM., vol. 55, no. 7, 3 April 2012 (2012-04-03)
Attorney, Agent or Firm:
TSINGYIHUA INTELLECTUAL PROPERTY LLC (Trade Building Zhaolanyuan,Tsinghua University, Qinghuayuan, Haidian District, Beijing 4, CN)
Download PDF:
Previous Patent: METHOD AND DEVICE FOR IDENTIFYING WEBPAGE INTRUSION SCRIPT FEATURES
Next Patent: GASTRIC TUBE
Next Patent: GASTRIC TUBE